Alimova D.A.

4 ta ish

Tashkent Pediatric Medical Institute

1. Prospects for the use of artificial intelligence technologies in predicting the risk of cardiovascular disease (CVD) outcomes in patients with type 2 diabetes mellitus

   Alimova D.A., Alisher Ikramov, Trigulova R.Kh. +4

   MaqolaOAOchiq kirishHermeneutics and Narrative IdentityZenodo (CERN European Organization for Nuclear Research)20220 iqtibos

   ABIABI:AkademIndex/2022.article.007831

2. Prospects for the use of artificial intelligence technologies in predicting the risk of cardiovascular disease (CVD) outcomes in patients with type 2 diabetes mellitus

   Alimova D.A., Alisher Ikramov, Раиса Тригулова +4

   MaqolaOAOchiq kirishHermeneutics and Narrative IdentityZenodo (CERN European Organization for Nuclear Research)20220 iqtibos

   ABIABI:AkademIndex/2022.article.009276

3. Prospects for the use of artificial intelligence technologies in predicting the risk of cardiovascular disease (CVD) outcomes in patients with type 2 diabetes mellitus

   Alimova D.A., Alisher Ikramov, Раиса Тригулова +4

   MaqolaHealthcare Systems and Public HealthZenodo (CERN European Organization for Nuclear Research)20230 iqtibos

   ABIABI:AkademIndex/2023.article.005541

4. Interrelations Between Glycated Hemoglobin Trajectories and Left Ventricular Diastolic Dysfunction in Patients with CHD and DM-2

   Alimova D.A., Mukhtarova Sh.Sh., Trigulova R.Kh. +5

   MaqolaCardiovascular Function and Risk FactorsAmerican Heart Journal20230 iqtibos

   ABIABI:AkademIndex/2023.article.011981